3-(2-METHOXYPHENYL) PIPERIDINE HYDROCHLORIDE
- $325 - $802.73
- Product name: 3-(2-METHOXYPHENYL) PIPERIDINE HYDROCHLORIDE
- CAS: 19725-12-3
- MF: C12H18ClNO
- MW: 227.73
- EINECS:
- MDL Number:MFCD02178953
- Synonyms:3-(2-METHOXYPHENYL) PIPERIDINE HYDROCHLORIDE;3-(2-methoxyphenyl)piperidine HCl
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAK Scientific
- Product number6640AD
- Product description3-(2-Methoxyphenyl)piperidinehydrochloride
- Packaging1g
- Price$725
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0084758
- Product description3-(2-METHOXYPHENYL)PIPERIDINE HYDROCHLORIDE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number021678
- Product description3-(2-Methoxyphenyl)piperidine hydrochloride
- Packaging500mg
- Price$325
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number021678
- Product description3-(2-Methoxyphenyl)piperidine hydrochloride
- Packaging1g
- Price$500
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 6640AD | 3-(2-Methoxyphenyl)piperidinehydrochloride | 1g | $725 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0084758 | 3-(2-METHOXYPHENYL)PIPERIDINE HYDROCHLORIDE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
Matrix Scientific | 021678 | 3-(2-Methoxyphenyl)piperidine hydrochloride | 500mg | $325 | 2021-12-16 | Buy |
Matrix Scientific | 021678 | 3-(2-Methoxyphenyl)piperidine hydrochloride | 1g | $500 | 2021-12-16 | Buy |
Properties
Melting point :158 °C
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|